Department of Neurology, Nissan Tamagawa Hospital, Seta 4-8-1, Setagaya, Tokyo 158-0095, Japan.
Department of Emergency, Nissan Tamagawa Hospital, Setagaya, Tokyo, Japan.
J Stroke Cerebrovasc Dis. 2021 Jan;30(1):105320. doi: 10.1016/j.jstrokecerebrovasdis.2020.105320. Epub 2020 Oct 31.
We herein report a case involving a 32-year-old Japanese man with recurrent cerebral venous thrombosis due to hereditary protein C deficiency. He was admitted to our hospital with impaired consciousness. Brain magnetic resonance imaging demonstrated high intensities diffusely along the bilateral sulci and magnetic resonance venography revealed left transverse sinus and superior sagittal sinus stenoses. His father had a history of cerebral infarction and venous thrombosis. The protein C activity level examined by chromogenic synthetic substrate assay was markedly reduced. He was diagnosed with protein C deficiency, and a genetic analysis revealed a heterozygous mutation at exon 3 c.199G>A,p.Glu67Lys on the protein C gene. Four months later, at his second admission, he had transient aphasia, and his protein C activity was under 10%. We switched warfarin to the direct oral anticoagulants edoxaban. He remains fully recovered with no adverse events after the administration of edoxaban for a year. Direct oral anticoagulants may be a new tool for treating cerebral venous thrombosis due to hereditary protein C deficiency.
我们在此报告一例因遗传性蛋白 C 缺乏导致复发性脑静脉血栓形成的 32 岁日本男性患者。他因意识障碍而入院。脑磁共振成像显示双侧脑沟弥漫性高信号,磁共振静脉造影显示左侧横窦和上矢状窦狭窄。他的父亲有脑梗死和静脉血栓形成病史。色原性合成底物检测法检测的蛋白 C 活性水平显著降低。他被诊断为蛋白 C 缺乏症,基因分析显示蛋白 C 基因外显子 3 c.199G>A,p.Glu67Lys 杂合突变。四个月后,他第二次入院时出现短暂性失语,蛋白 C 活性低于 10%。我们将华法林转换为直接口服抗凝剂依度沙班。依度沙班治疗一年后,他完全恢复,无不良事件发生。直接口服抗凝剂可能成为治疗遗传性蛋白 C 缺乏引起的脑静脉血栓形成的新方法。